Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calavo Growers (CVGW) Cash & Equivalents (2016 - 2026)

Calavo Growers (CVGW) has 16 years of Cash & Equivalents data on record, last reported at $61.2 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 7.23% year-over-year to $61.2 million; the TTM value through Oct 2025 reached $61.2 million, up 7.23%, while the annual FY2025 figure was $61.2 million, 7.23% up from the prior year.
  • Cash & Equivalents reached $61.2 million in Q4 2025 per CVGW's latest filing, down from $63.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $63.8 million in Q3 2025 and bottomed at $368000.0 in Q3 2021.
  • Average Cash & Equivalents over 5 years is $17.1 million, with a median of $4.2 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: crashed 89.7% in 2021, then surged 5561.99% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $1.9 million in 2021, then increased by 9.28% to $2.1 million in 2022, then increased by 1.5% to $2.1 million in 2023, then surged by 2627.45% to $57.0 million in 2024, then rose by 7.23% to $61.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $61.2 million in Q4 2025, $63.8 million in Q3 2025, and $60.4 million in Q2 2025.